share_log

Critical Insights From Merck & Co Analyst Ratings: What You Need To Know

Critical Insights From Merck & Co Analyst Ratings: What You Need To Know

來自默沙東分析師評級的關鍵見解:你需要知道的
Benzinga ·  02/29 14:01
In the preceding three months, 10 analysts have released ratings for Merck & Co (NYSE:MRK), presenting a wide array of perspectives from bullish to bearish.
在過去的三個月中,10位分析師發佈了默沙東公司(紐約證券交易所代碼:MRK)的評級,提出了從看漲到看跌的各種觀點。
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
在下表中,您將找到他們最近的評級摘要,揭示了過去30天中情緒的變化,並將其與前幾個月進行了比較。
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $137.2, with a high estimate of $148.00 and a low estimate of $130.00. This upward trend is apparent, with the current average reflecting a 6.63% increase from the previous average price target of $128.67.
分析師對12個月目標股價的評估提供了更多見解,顯示平均目標價爲137.2美元,最高估計爲148.00美元,低估值爲130.00美元。這種上升趨勢顯而易見,當前的平均價格較之前的平均目標價128.67美元上漲了6.63%。
Diving into Analyst Ratings...
深入分析...
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論